California鈥檚 Latino Doctors Push For More Of Their Own
More than one-third of the state鈥檚 Latino physicians plan to retire within the next 10 years, according to a new survey.
Health Industry
2,601 - 2,620 of 3,879 Results
-
-
California Reforms Target Workers鈥 Compensation Fraud
Two new laws will prohibit felons from billing for workers' comp and rein in unsanctioned treatment.
-
Hospitals Say They鈥檙e Being Slammed By Drug Price Hikes
In a report out Tuesday, hospital groups said drug prices have skyrocketed since 2013, triggering a huge increase in what hospitals spend on pharmaceuticals.
-
California Won鈥檛 Extend Parental Leave Rights To Small Businesses
Gov. Jerry Brown vetoes a bill that would have guaranteed employees of small businesses can keep their jobs if they take parental leave to bond with a new child.
-
A Bygone Era: When Bipartisanship Led To Health Care Transformation
A federal law enacted shortly after the end of World War II provided grants and loans to fund hospital construction that have left a lasting legacy.
-
Tracking Who Makes Money On A Brand-Name Drug
KHN鈥檚 Julie Appleby joined forces with USA Today to create this chart, which details the various industry players and how they contribute to a prescription drug鈥檚 cost.
-
Pricey New Treatment Roils Issues Of How To Treat Prostate Cancer
High-intensity focused ultrasound, often not covered by insurance, leads to discussions about which patients benefit in the real world.
-
Young Boy鈥檚 Struggle To Survive Sparked Push For Drugs For Terminally Ill
Ten-year-old Josh Hardy died last month. His struggle to survive helped to spur laws to get unapproved drugs to the terminally ill.
By Liz Szabo -
Most Hospital Palliative Care Programs Are Understaffed
Guidelines recommend that hospitals have a physician, an advanced practice or registered nurse, a social worker and chaplain on the palliative care team, but only about 25 percent of hospitals meet that standard.
-
The Orphan Drug Machine
A Golden Ticket That Fast-Tracks A Drug Through The FDA
A voucher awarded to companies that find treatments for rare childhood diseases can be sold to the highest bidder 鈥 and then used to speed up approvals for much more common drugs.
-
When Drug Reviewers Leave The FDA, They Often Work For Pharma
Researchers examine the Food and Drug Administration鈥檚 鈥渞evolving door鈥 regarding employees who worked on cancer and hematology drugs.
-
Seattle Dentists, Clinics And A Hospital Partner To Provide Specialty Care For Teeth
A pilot project involving Swedish Medical Center and the Neighborcare Health network of community clinics offers care for uninsured adults or those on Medicaid.
By Zhai Yun Tan -
The Ads Say 鈥楪et Your Flu Shot Today,鈥 But It May Be Wiser To Wait
The flu vaccine is available for longer windows of time. Experts say to weigh convenience and science in deciding when to roll up your sleeve.
-
CDC Deploys New Rapid Response Teams To Fight Zika
Based on lessons learned in the 2014 Ebola outbreak, the federal agency has designated teams to help identify patients and health care workers who have been exposed to the virus.
-
Insurers May Insist On Counseling Before Genetic Tests For Breast Cancer
Doctors are concerned that requiring referrals to genetic counselors can deter women from going forward with testing for genetic mutations that cause breast cancer.
-
Study: Health Spending Related To Opioid Treatment Rose More Than 1,300 Percent
Based on an analysis of insurance company payments, emergency room visits and lab tests were responsible for much of the overall spending.
-
Tossing Unused Surgical Supplies Wastes Millions Of Dollars, Study Finds
Researchers at the University of California, San Francisco estimate that hospitals could lose nearly $1,000 per surgery by throwing away opened but unused supplies, such as gloves and sponges.
-
Consumer Group Questions Role of Drug Costs In California Premium Hikes
Consumers Union says Anthem Inc. and Blue Shield of California may be exploiting furor over prescription drug prices. State regulators are looking into the issue.
By Chad Terhune -
Behind The EpiPen Monopoly: Lobbying Muscle, Flailing Competition, Tragic Deaths
A closer look shows that industry lobbying was just one factor in EpiPen鈥檚 sales explosion.
-
Study Finds Seniors Benefit When Asked How To Help Them
A federally funded research project in Baltimore has potential to help aging-in-place efforts elsewhere, a study in Health Affairs reports.
By Rachel Bluth